Regulatory Framework Overview
Thai FDA · MDCD · Medical Device Act B.E. 2562 · ASEAN AMDD
Thai FDA and the MDCD
The Food and Drug Administration (Thai FDA) operates under the Ministry of Public Health (MoPH). Within the Thai FDA, the Medical Device Control Division (MDCD) handles all medical device regulation:
| Function | Body |
|---|---|
| Registration applications (Listing/Notification/License) | MDCD |
| Establishment License issuance | MDCD |
| Post-market surveillance | MDCD |
| Recall and enforcement coordination | MDCD |
| Guidance and policy development | MDCD / Thai FDA |
| Wireless device spectrum approval (separate) | NBTC (independent body) |
Buddhist Era (B.E.) Year System — TH-Unique
Thailand uses the Buddhist Era (B.E.) calendar alongside the Common Era (CE). B.E. year = CE year + 543.
| CE Year | B.E. Year |
|---|---|
| 2019 | 2562 |
| 2021 | 2564 |
| 2023 | 2566 |
| 2024 | 2567 |
| 2025 | 2568 |
| 2026 | 2569 |
All Thai legislation, ministerial notifications, and official documents use B.E. dating. When reading Thai regulatory documents, apply the formula: B.E. − 543 = CE year.
Primary Legislation — Medical Device Act B.E. 2562 (2019)
- Enacted: 2019 (B.E. 2562)
- In force: 15 February 2021 (B.E. 2564)
- Replaced: The former Medical Device Act B.E. 2551 (2008)
The 2019 Act:
- Introduced the Class 1–4 risk classification aligned with ASEAN AMDD
- Established three distinct approval pathways (Listing / Notification / License)
- Made Establishment Licenses mandatory for all manufacturers and importers
- Required the CSDT (Common Submission Dossier Template) for Class 2–4 submissions
- Introduced 5-year approval validity for all approval types
- Provided for a Thai Authorized Representative requirement for foreign manufacturers
ASEAN AMDD Alignment — TH-Unique
Thailand is a full participant in the ASEAN Harmonized Medical Device Regulatory Framework and has implemented the ASEAN Medical Device Directive (AMDD). This means:
- Classification rules are based on ASEAN AMDD risk-based principles
- Dossier format follows the ASEAN Common Submission Dossier Template (CSDT)
- Thailand's framework is broadly compatible with Malaysia (MDA), Indonesia (BPOM), Philippines (FDA), Vietnam (DAV), Singapore (HSA), and other ASEAN markets
- ASEAN AMDD alignment enables the Concise/Reliance route for devices approved by recognised NRAs
Regulatory Reform — 2021 New Framework
The shift to the 2019 Act (in force Feb 2021) represented a major reform:
- All new applications since 15 February 2021 must follow the new 2019 Act framework
- Devices registered under the previous 2008 Act framework continue to be valid but are subject to renewal under the new system
- The new framework provides more structured pathways and clearer timelines compared to the old system